<DOC>
	<DOCNO>NCT03008655</DOCNO>
	<brief_summary>BACKGROUND : Melasma chronic , often relapse skin disorder , poor long-term result current therapies.Q switch 1064nm Nd : YAG laser intradermal tranexamic acid show efficacy treatment melasma . However , combination therapy report . OBJECTIVES : To compare efficacy low influence Q switch 1064nm Nd : YAG laser low influence Q switch 1064nm Nd : YAG laser combine intradermal tranexamic acid injection melasma .</brief_summary>
	<brief_title>1064-nm Q-switched Nd : YAG Laser Intradermal Tranexamic Acid Melasma</brief_title>
	<detailed_description>METHODS : Twenty patient melasma include randomize control observer-blinded study split-face design . Each side face randomly allocate either six session two-week interval low influence 1064 Nd : YAG laser ( 6 mm spot size , energy fluence 1.2 - 1.4 J/cm 2 10 Hz ) low influence 1064nm Nd : YAG laser combine intradermal tranexamic acid injection.Complication Improvement melasma assess Melasma area severity index ( MASI ) , physician 's global assessment ( PhGA ) , MELASQOL scale , patient 's global assessment ( PGA ) , patient 's satisfaction baseline,6th week,10th week first treatment 3 month , 6 month last treatment .</detailed_description>
	<mesh_term>Melanosis</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>patient &gt; 20 year old refractory melasma topical treatment History keloid , active eczema , active acne face , history facial eczema , photosensitivity , use isotretinoin past 6 month , pregnancy , high exposure sunlight UV light ( UVA UVB )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>